Wird geladen...
Qualitative and quantitative measures of various compounded formulations of 17-hydroxyprogesterone caproate
OBJECTIVES: 17-hydroxyprogesterone caproate (17-OHPC) is available both as an FDA – approved medication and as a product prepared for individual patients by compounding pharmacies. Compounding pharmacies may omit the preservative used in the FDA approved formulation or use an alternate preservative...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3672260/ https://ncbi.nlm.nih.gov/pubmed/23453884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2013.02.028 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|